Education
About Us
Working with TipRanks
Follow Us
Ramm Pharma Corp (TSE:RAMM)
:RAMM
Total Valuation
Ramm Pharma has a market cap or net worth of C$1.19M. The enterprise value is ―.
Market CapC$1.19M
Enterprise Value―
Share Statistics
Ramm Pharma has 119,389,320 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding119,389,320
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ramm Pharma’s return on equity (ROE) is -1.21 and return on invested capital (ROIC) is -48.93%.
Return on Equity (ROE)-1.21
Return on Assets (ROA)-0.99
Return on Invested Capital (ROIC)-48.93%
Return on Capital Employed (ROCE)-0.49
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.26
Inventory Turnover1.01
Valuation Ratios
The current PE Ratio of Ramm Pharma is -0.07. Ramm Pharma’s PEG ratio is -0.02.
PE Ratio-0.07
PS Ratio0.00
PB Ratio0.19
Price to Fair Value0.09
Price to FCF-0.77
Price to Operating Cash Flow-0.78
PEG Ratio-0.02
Income Statement
In the last 12 months, Ramm Pharma had revenue of 4.34M and earned -16.50M in profits. Earnings per share was -0.14.
Revenue4.34M
Gross Profit1.76M
Operating Income-6.76M
Pretax Income-16.49M
Net Income-16.50M
EBITDA-15.23M
Earnings Per Share (EPS)-0.14
Cash Flow
In the last 12 months, operating cash flow was -3.04M and capital expenditures -59.43K, giving a free cash flow of -3.10M billion.
Operating Cash Flow-3.04M
Free Cash Flow-3.10M
Free Cash Flow per Share-0.03
Dividends & Yields
Ramm Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.92
52-Week Price Change-66.67%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)0.21
Average Volume (3m)638.00
Important Dates
Ramm Pharma upcoming earnings date is Jul 1, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateJul 1, 2025
Ex-Dividend Date―
Financial Position
Ramm Pharma as a current ratio of 1.77, with Debt / Equity ratio of 1.59%
Current Ratio1.77
Quick Ratio0.93
Debt to Market Cap0.00
Net Debt to EBITDA0.04
Interest Coverage Ratio-115.27
Taxes
In the past 12 months, Ramm Pharma has paid 8.12K in taxes.
Income Tax8.12K
Effective Tax Rate>-0.01
Enterprise Valuation
Ramm Pharma EV to EBITDA ratio is -0.04, with an EV/FCF ratio of -0.14.
EV to Sales0.13
EV to EBITDA-0.04
EV to Free Cash Flow-0.14
EV to Operating Cash Flow-0.14
Balance Sheet
Ramm Pharma has C$480.44K in cash and marketable securities with C$197.69K in debt, giving a net cash position of -C$282.75K billion.
Cash & Marketable SecuritiesC$480.44K
Total DebtC$197.69K
Net Cash-C$282.75K
Net Cash Per Share>-C$0.01
Tangible Book Value Per ShareC$0.11
Margins
Gross margin is 32.77%, with operating margin of -155.68%, and net profit margin of -380.06%.
Gross Margin32.77%
Operating Margin-155.68%
Pretax Margin-379.87%
Net Profit Margin-380.06%
EBITDA Margin-350.74%
EBIT Margin-378.86%
Analyst Forecast
The average price target for Ramm Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-6.32%
EPS Growth Forecast-83.07%